NMDAR antagonist 1 |
Catalog No.GC34352 |
NMDAR antagonist 1 is a potent and orally bioavailable NR2B-selective NMDAR antagonist.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2220162-06-9
Sample solution is provided at 25 µL, 10mM.
NMDAR antagonist 1 is a potent and orally bioavailable NR2B-selective NMDAR antagonist[1].
NMDAR antagonist 1 (Compound 5q) exhibits excellent neuroprotective activity[1]. NMDAR antagonist 1 can attenuate Ca2+ influx induced by NMDA[1].NMDAR antagonist 1 can suppress the NR2B up-regulation and increase p-ERK1/2 expression[1].NMDAR antagonist 1 inhibits SH-SY5Y cells with cell viabilities of 75.8%, 80.0%, 84.4%, and 78.6% at 0.1 µM 1 µM 10 µM 100 µM, respectively[1].
[1]. Zhang L, et al. Design, synthesis and bioevaluation of 1,2,3,9-tetrahydropyrrolo[2,1-b]quinazoline-1-carboxylic acid derivatives as potent neuroprotective agents. Eur J Med Chem. 2018 May 10;151:27-38.
Average Rating: 5
(Based on Reviews and 19 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *